ArticleEye (London, England)2026

Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration.

Pierluigi Daniele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.